Doximity, Inc.
Moat Score — Doximity, Inc.
Total Moat Score
18 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | Doximity holds validated professional-identity data on over 80% of U.S. physicians, a proprietary dataset of specialty, practice setting, and engagement behavior that would be extremely costly for a new entrant to recreate, though it is less a patent/IP moat than a data and trust-based one. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 3 / 5 | Because the core network and workflow tools are free and physician-generated, Doximity's incremental cost to serve an already-engaged member base is low, producing a 39.1% GAAP net income margin and 55% adjusted EBITDA margin in fiscal 2025 that few digital advertising or SaaS peers can match. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 3 / 5 | Pharmaceutical manufacturers pay a premium for Doximity's precisely-targeted physician reach versus generic digital advertising, and 20%+ revenue growth alongside expanding margins suggests Doximity can grow pricing/value capture per customer without a corresponding cost increase. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 4 / 5 | Doximity exhibits a genuine two-sided network effect: more physicians joining makes the platform more valuable to pharma/health-system advertisers and recruiters, while more relevant sponsored content and job opportunities make the platform more valuable to physicians, reinforcing the >80% U.S. physician penetration that is difficult for a new entrant to replicate. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | Individual physicians face low switching costs to stop using Doximity's free tools, but paying customers (pharma marketing teams) face moderate switching costs once campaigns, targeting data, and creative are built around Doximity's specific audience and modules, and physicians who have built a professional profile/connections over years are less likely to migrate to an alternative. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 3 / 5 | The market for a single, dominant medical-professional network is naturally limited to one or two winners given network effects, and Doximity's entrenched >80% physician penetration makes it economically unattractive for a new, well-funded entrant to try to build a competing medical-only network from scratch. |